Invention Grant
- Patent Title: Influenza H5 vaccines
-
Application No.: US15662358Application Date: 2017-07-28
-
Publication No.: US10369211B2Publication Date: 2019-08-06
- Inventor: Mauricio Realpe-Quintero , Paulino Carlos Gonzalez-Hernandez , Eric Vaughn
- Applicant: Boehringer Ingelheim Vetmedica GmbH , Boehringer Ingelheim Vetmedica S.A. de C.V.
- Agent Judy Jarecki-Black
- Main IPC: A61K39/145
- IPC: A61K39/145 ; A61K39/17 ; C07K14/005 ; A61K39/12 ; A61K39/00

Abstract:
The present invention is based on the surprising finding that H5 protein of clade 1 H5N1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with H5N1 HA.In one aspect, the invention is thus directed to H5 protein of clade 1 H5N1 virus for use in a method of treating or preventing infections with H5N1 virus of a different clade, namely of a clade different from clade 1 or from any clade with the exception of clade 1, respectively.
Public/Granted literature
- US20170348413A1 INFLUENZA H5 VACCINES Public/Granted day:2017-12-07
Information query